We are live on ! Find out more
HRMY icon

Harmony Biosciences

147 hedge funds and large institutions have $1.9B invested in Harmony Biosciences in 2021 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 40 increasing their positions, 31 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

329% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 14

60% more capital invested

Capital invested by funds: $1.19B → $1.9B (+$714M)

44% more funds holding

Funds holding: 102147 (+45)

33% more funds holding in top 10

Funds holding in top 10: 68 (+2)

29% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 31

21.95% more ownership

Funds ownership: 54.26%76.21% (+22%)

Holders
147
Holders Change
+45
Holders Change %
+44.12%
% of All Funds
2.26%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
60
Increased
40
Reduced
31
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ECM
101
ExodusPoint Capital Management
New York
$381K -$3.14M -78,780 -90%
DTL
102
Dynamic Technology Lab
Singapore
$379K +$27.9K +700 +9%
VOYA Investment Management
103
VOYA Investment Management
Georgia
$376K -$1.71K -43 -0.5%
Russell Investments Group
104
Russell Investments Group
United Kingdom
$348K +$92.5K +2,321 +40%
Handelsbanken Fonder
105
Handelsbanken Fonder
Sweden
$345K +$323K +8,100 New
OPERF
106
Oregon Public Employees Retirement Fund
Oregon
$321K +$300K +7,533 New
Susquehanna International Group
107
Susquehanna International Group
Pennsylvania
$315K +$294K +7,376 New
DCM
108
Dupont Capital Management
Delaware
$307K -$114K -2,871 -29%
WG
109
Winton Group
United Kingdom
$296K +$276K +6,932 New
New York State Teachers Retirement System (NYSTRS)
110
New York State Teachers Retirement System (NYSTRS)
New York
$292K +$273K +6,852 New
Rafferty Asset Management
111
Rafferty Asset Management
New York
$281K +$262K +6,585 New
T. Rowe Price Associates
112
T. Rowe Price Associates
Maryland
$280K +$262K +6,565 New
TRSOTSOK
113
Teachers Retirement System of the State of Kentucky
Kentucky
$273K +$255K +6,400 New
Bank of Montreal
114
Bank of Montreal
Ontario, Canada
$263K +$236K +5,920 New
MLICM
115
Metropolitan Life Insurance Company (MetLife)
New York
$258K -$43.9K -1,102 -15%
GCP
116
GSA Capital Partners
United Kingdom
$215K +$201K +5,037 New
Royal Bank of Canada
117
Royal Bank of Canada
Ontario, Canada
$206K +$63.2K +1,586 +49%
Zurich Cantonal Bank
118
Zurich Cantonal Bank
Switzerland
$185K +$173K +4,330 New
MOACM
119
Mutual of America Capital Management
New York
$133K +$124K +3,115 New
Acadian Asset Management
120
Acadian Asset Management
Massachusetts
$84K +$79.1K +1,984 New
QT
121
Quantbot Technologies
New York
$81K +$75.7K +1,900 New
AIP
122
Ameritas Investment Partners
Nebraska
$75K
AS
123
Altshuler Shaham
Israel
$51K +$47.9K +1,202 New
MSFP
124
Mark Sheptoff Financial Planning
Connecticut
$43K +$39.9K +1,000 New
PNC Financial Services Group
125
PNC Financial Services Group
Pennsylvania
$37K +$34.5K +866 New

HRMY Hedge Fund Activity: Q4 2021 in Review

147 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q4 2021, worth a combined $1.9B — up 60% from $1.19B a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new HRMY positions and 14 closed out — a net gain of 46 holders — while 40 added to existing stakes and 31 trimmed.

The largest buyer was BlackRock, adding an estimated $84.7M. The largest seller was Newlight Partners, cutting an estimated $39.9M.

  • 147 institutional investors held Harmony Biosciences (HRMY) as of Q4 2021, up from 102 in Q3 2021.
  • Funds reported $1.9B of Harmony Biosciences stock for Q4 2021, up 60% quarter-over-quarter.
  • 60 funds opened new Harmony Biosciences positions in Q4 2021 and 14 closed out, a net change of +46 holders.
  • The largest Harmony Biosciences buyer in Q4 2021 was BlackRock, an estimated $84.7M added.
  • The largest Harmony Biosciences seller in Q4 2021 was Newlight Partners, an estimated $39.9M sold.

Based on aggregated 13F filings for Q4 2021.